Workflow
CONMED (CNMD)
icon
Search documents
CONMED (CNMD) - 2022 Q1 - Earnings Call Presentation
2022-05-06 20:46
| --- | --- | |----------------------------------------------------------------------------|-------------------------------| | | | | | | | | | | | | | | | | Investor Presentation Q1 2022 Earnings | and In2Bones Acquisition Call | | Curt R. Hartman Chair of the Board, President, and Chief Executive Officer | | Todd W. Garner Executive Vice President and Chief Financial Officer May 4, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contin ...
CONMED (CNMD) - 2022 Q1 - Quarterly Report
2022-05-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...
CONMED (CNMD) - 2021 Q4 - Annual Report
2022-02-21 16:00
Common Stock, $0.01 par value CNMD NYSE United States Securities and Exchange Commission Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: December 31, 2021 Commission file number: 001-39218 | --- | --- | |-----------------------------------------------------|------------------------------------------------------------- ...
CONMED (CNMD) - 2021 Q4 - Earnings Call Transcript
2022-01-27 00:24
CONMED Corporation (NYSE:CNMD) Q4 2021 Earnings Conference Call January 26, 2022 4:30 PM ET Company Participants Julie Hall - Corporate Communications Manager & Executive Assistant to Executive VP-HR Curt Hartman - Chair of the Board, President and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Robbie Marcus - JPMorgan Matthew O’Brien - Piper Sandler Young Li - UBS Matthew Mishan - KeyBanc Mike Matson - Needham & Com ...
CONMED (CNMD) - 2021 Q4 - Earnings Call Presentation
2022-01-26 22:11
Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer January 26, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's ...
CONMED (CNMD) - 2021 Q3 - Earnings Call Presentation
2021-10-28 15:24
Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer October 27, 2021 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's ...
CONMED (CNMD) - 2021 Q3 - Earnings Call Transcript
2021-10-28 02:27
CONMED Corporation (NYSE:CNMD) Q3 2021 Earnings Conference Call October 27, 2021 4:30 PM ET Company Participants Julie Hall – Corporate Communications Manager and Executive Assistant to Executive Vice President-HR Curt Hartman – Chair of the Board, President and Chief Executive Officer Todd Garner – Executive Vice President and Chief Financial Officer Conference Call Participants Travis Steed – Barclays Robbie Marcus – J.P. Morgan Young Li – UBS Mike Matson – Needham & Company Rick Wise – Stifel Matthew Mis ...
CONMED (CNMD) - 2021 Q3 - Quarterly Report
2021-10-27 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...
CONMED (CNMD) - 2021 Q2 - Earnings Call Presentation
2021-07-30 12:10
Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer July 28, 2021 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's per ...
CONMED (CNMD) - 2021 Q2 - Earnings Call Transcript
2021-07-29 02:59
CONMED Corporation (NYSE:CNMD) Q2 2021 Earnings Conference Call July 28, 2021 4:30 PM ET Company Participants Julie Hall - Corporate Communications Manager & Executive Assistant to the EVP HR Curt Hartman - Chairman, President and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Robbie Marcus - JP Morgan Travis Steed - Barclays Young Li - UBS Mike Matson - Needham & Company Matt Mishan - KeyBanc Operator Good day and t ...